Ligand Pharmaceuticals | Umsatzkosten



Cost Of Sales Veränderung Datum
Amgen USD 3.01B 406M 2025-06
Baxter International USD 1.82B 55M 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Eli Lilly USD 2.45B 223.6M 2025-06
Gilead Sciences USD 1.5B 39M 2025-06
GlaxoSmithKline GBP 2.16B 241M 2025-06
Glaxosmithkline GBP 2.52B 199M 2024-12
Insmed USD 29.34M 8.06M 2025-06
Ionis Pharmaceuticals USD 4.15M 3.15M 2025-06
Ligand Pharmaceuticals USD 11.16M 6.32M 2025-06
MacroGenics USD 5.49M 3.62M 2024-12
Merck USD 2.82B 53M 2025-06
Pacira USD 55.19M 20.88M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Veracyte USD 41.02M 6.05M 2025-06


Ligand Pharmaceuticals Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.